Vaccine protection against Zika virus from Brazil.
Vaccine protection against Zika virus from Brazil.
复制标题
DOI:
10.1038/nature18952
复制
发表时间:
2016-08-25
期刊:
影响因子:
64.8
通讯作者:
Barouch, Dan H.
中科院分区:
文献类型:
--
作者:
Larocca, Rafael A.;Abbink, Peter;Peron, Jean Pierre S.;Zanotto, Paolo M. de A.;Iampietro, M. Justin;Badamchi-Zadeh, Alexander;Boyd, Michael;Ng'ang'a, David;Kirilova, Marinela;Nityanandam, Ramya;Mercado, Noe B.;Li, Zhenfeng;Moseley, Edward T.;Bricault, Christine A.;Borducchi, Erica N.;Giglio, Patricia B.;Jetton, David;Neubauer, George;Nkolola, Joseph P.;Maxfield, Lori F.;De La Barrera, Rafael A.;Jarman, Richard G.;Eckels, Kenneth H.;Michael, Nelson L.;Thomas, Stephen J.;Barouch, Dan H.
Zika virus (ZIKV) is a flavivirus that is responsible for an unprecedented current epidemic in Brazil and the Americas. ZIKV has been causally associated with fetal microcephaly, intrauterine growth restriction, and other birth defects in both humans and mice. The rapid development of a safe and effective ZIKV vaccine is a global health priority, but very little is currently known about ZIKV immunology and mechanisms of immune protection. Here we show that a single immunization of a plasmid DNA vaccine or a purified inactivated virus vaccine provides complete protection in susceptible mice against challenge with a ZIKV outbreak strain from northeast Brazil. This ZIKV strain has recently been shown to cross the placenta and to induce fetal microcephaly and other congenital malformations in mice. We produced DNA vaccines expressing full-length ZIKV pre-membrane and envelope (prM-Env) as well as a series of deletion mutants. The full-length prM-Env DNA vaccine, but not the deletion mutants, afforded complete protection against ZIKV as measured by absence of detectable viremia following challenge, and protective efficacy correlated with Env-specific antibody titers. Adoptive transfer of purified IgG from vaccinated mice conferred passive protection, and CD4 and CD8 T lymphocyte depletion in vaccinated mice did not abrogate protective efficacy. These data demonstrate that protection against ZIKV challenge can be achieved by single-shot subunit and inactivated virus vaccines in mice and that Env-specific antibody titers represent key immunologic correlates of protection. Our findings suggest that the development of a ZIKV vaccine for humans will likely be readily achievable.
登录
查看更多内容
DOI:
10.1126/science.aaf5036
发表时间:
2016-04-15
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Faria NR;Azevedo RDSDS;Kraemer MUG;Souza R;Cunha MS;Hill SC;Thézé J;Bonsall MB;Bowden TA;Rissanen I;Rocco IM;Nogueira JS;Maeda AY;Vasami FGDS;Macedo FLL;Suzuki A;Rodrigues SG;Cruz ACR;Nunes BT;Medeiros DBA;Rodrigues DSG;Queiroz ALN;da Silva EVP;Henriques DF;da Rosa EST;de Oliveira CS;Martins LC;Vasconcelos HB;Casseb LMN;Simith DB;Messina JP;Abade L;Lourenço J;Alcantara LCJ;de Lima MM;Giovanetti M;Hay SI;de Oliveira RS;Lemos PDS;de Oliveira LF;de Lima CPS;da Silva SP;de Vasconcelos JM;Franco L;Cardoso JF;Vianez-Júnior JLDSG;Mir D;Bello G;Delatorre E;Khan K;Creatore M;Coelho GE;de Oliveira WK;Tesh R;Pybus OG;Nunes MRT;Vasconcelos PFC
通讯作者:
Vasconcelos PFC
DOI:
10.4269/ajtmh.2012.12-0361
发表时间:
2013-01
期刊:
The American journal of tropical medicine and hygiene
影响因子:
--
作者:
Thomas SJ;Eckels KH;Carletti I;De La Barrera R;Dessy F;Fernandez S;Putnak R;Toussaint JF;Sun W;Bauer K;Gibbons RV;Innis BL
通讯作者:
Innis BL
影响因子:
158.5
作者:
Driggers, R. W.;Ho, C. -Y.;Vapalahti, O.
通讯作者:
Vapalahti, O.
DOI:
10.4269/ajtmh.16-0111
发表时间:
2016-06-01
期刊:
The American journal of tropical medicine and hygiene
影响因子:
--
作者:
Rossi SL;Tesh RB;Azar SR;Muruato AE;Hanley KA;Auguste AJ;Langsjoen RM;Paessler S;Vasilakis N;Weaver SC
通讯作者:
Weaver SC
影响因子:
6.4
作者:
Martin, Julie E.;Pierson, Theodore C.;Graham, Barney S.
通讯作者:
Graham, Barney S.